跳至主要内容
临床试验/NCT02028104
NCT02028104撤回1 期

Open Label Study of Autologous Bone Marrow Mononuclear Cells in Traumatic Brain Injury

Neurogen Brain and Spine Institute2 个研究点 分布在 1 个国家开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
1 期
状态
撤回
试验地点
2
主要终点
Change in clinical symptoms of traumatic brain injury

研究概览

简要总结

The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with Traumatic Brain Injury

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Months 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed cases of chronic traumatic brain injury
  • Age above 6 months

排除标准

  • presence of acute infections such as Human immunodeficiency virus/Hepatitis B - Virus/Hepatitis C Virus
  • malignancies
  • bleeding tendencies
  • pneumonia
  • renal failure
  • severe liver dysfunction
  • severe anemia [Hemoglobin < 8]
  • any bone marrow disorder
  • space occupying lesion in brain
  • other acute medical conditions such as respiratory infection and pyrexia
  • pregnancy
  • lactation

结局指标

主要结局

Change in clinical symptoms of traumatic brain injury

时间窗: 6 months

次要结局

  • Disability Rating scale(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验